CellOS
CellCo combines computational simulation, generative AI, and medicinal chemistry to engineer glycan-enabled therapeutics with unprecedented precision — turning complex molecular structures into programmable medicines.
Glyco-MD
Massively parallel molecular dynamics and free-energy prediction powered by custom force fields and automated cloud pipelines.
Synthetic Data
Order-of-magnitude expansion for scarce-data domains to train robust models.
Generative Engine
Training and fine-tuning models for glycans, RNA and complex biomolecular ensembles.
Glyco-LLMs
Foundation embeddings for oligosaccharides to assist glyco-therapeutic design.
20x more compounds screened
Our virtual screening pipeline processes orders of magnitude more compounds at the docking/AI stage compared to industry-standard workflows — delivering broader chemical coverage with precise physics-based validation.
Watch CellOS in action
The sugar code
Every cell is coated in a dense layer of sugar structures — glycans. They control immune recognition, cell signaling, and pathogen entry, yet remain mostly unknown — and almost entirely unexploited.

Advancing next-generation therapeutics
We work at the intersection of glycan chemistry, immune biology, and targeted delivery — each area reinforcing the others.
Glycan Programming
Speaking the language of glycans.
The glycan layer controls what enters every cell. We design molecules that speak its language — with atomic precision.
Immune Modulation
Precision immunology starts at the cell surface.
Macrophages, B cells, dendritic cells, neutrophils — each reads glycan signals differently. We exploit that specificity to modulate immune response with programmable precision.
Cell Specificity
Nature's address book.
Glycan ligands direct therapeutics to specific tissues and cell types — RNA, small molecules, antibodies. Leveraging Nature's own playbook.
Every tissue has its own code
Glycan ligands are the molecular addresses that direct therapeutics to specific tissues. We engineer these addresses computationally.
Cells that defend us
CellFlow
CellFlow assembles complex glycan libraries with enzymatic precision at synthetic speed — accessing molecular space that was never programmable before.
Essential Medicines Initiative
Advancing essential medicines for critical care scenarios where current options are limited, compromised, or don't yet exist.
Anticoagulant
Biosynthetic Heparin/Enoxaparin
Tissue Repair
Acute Endothelial & Epithelial Injury
Science-led. Computation-driven.


Leadership





Advisors



















